Haemonetics Corp (NYSE:HAE)
$ 95.27 -0.46 (-0.48%) Market Cap: 4.84 Bil Enterprise Value: 5.47 Bil PE Ratio: 41.60 PB Ratio: 5.04 GF Score: 84/100

Haemonetics Corp at Jefferies Virtual Plasma Summit Transcript

Mar 11, 2021 / 03:45PM GMT
Release Date Price: $118.83 (+0.21%)
Anthony Charles Petrone
Jefferies LLC, Research Division - Healthcare Analyst

Good morning, everyone, and welcome to the Jefferies First Annual Global Plasma Summit.

Up next, we have Haemonetics. With us, we have Chris Simon, the company's CEO. We have a half hour allotted here, and we're going to have a fireside chat discussion.

And so Chris, thank you for joining us today, and we hope you're doing well.

Christopher A. Simon
Haemonetics Corporation - CEO, President & Director

Thank you, Anthony. It's a pleasure to be here. Wish you well as well.

Questions & Answers

Anthony Charles Petrone
Jefferies LLC, Research Division - Healthcare Analyst

I think a good place to start. Of course, we had a morning session with Matt Hotchko from MRB. It's just sort of a bit of a post-mortem over the past year, where we've been through COVID as it relates to plasma collection cycles and sort of where we sit at the moment coming up to mid-March, the 1-year anniversary of the pandemic coming in?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot